Aster DM Healthcare and subsidiary MIMS revised their acquisition cost for a 26% stake in Oyster Green Hybrid Two to ₹5.8 crore from ₹7 crore due to lower project costs.
The investment, completed in two tranches (₹3.54 Cr on Oct 2, 2025 and ₹2.26 Cr on Apr 22, 2026), fulfills a statutory requirement for a captive 18 MWp solar power plant in Kerala.
The acquisition is not a related party transaction and aims to meet part of Aster and MIMS's electricity needs through renewable energy, with Oyster supplying 100% of the net output.